BIOLIFE SOLUTIONS INC — Director's Dealing 2023

Nov 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2023-10-19

Reporting Person: Richardson Garrie (Chief Revenue Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-19	Common Stock	A	36320	—	Acquired	105327	Direct

Footnotes

F1: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "Plan") and vests 25% on the first anniversary of the grant date and thereafter annually, in 4 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation in connection with their appointment as Chief Revenue Officer.